- Home
- ORIC vs CGBD Comparison
ORIC vs CGBD Comparison
Compare ORIC & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIC | CGBD |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | 104 | 2500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.3M | 826.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORIC | CGBD |
|---|---|---|
| Price | $8.30 | $10.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | ★ $19.73 | $12.92 |
| AVG Volume (30 Days) | ★ 1.2M | 567.1K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 14.42% |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.74 |
| Revenue Next Year | N/A | $1.80 |
| P/E Ratio | ★ N/A | $10.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.51 | $10.62 |
| 52 Week High | $14.93 | $14.32 |
Technical Indicators
Market Signals| Indicator | ORIC | CGBD |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 33.31 |
| Support Level | $7.90 | $10.68 |
| Resistance Level | $11.22 | $12.17 |
| Average True Range (ATR) | 0.44 | 0.30 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 30.75 | 3.80 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.